A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study to Compare the Safety and Efficacy of IDP-122 Lotion to Ultravate (Halobetasol Propionate) Cream, in the Treatment of Plaque Psoriasis
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Ulobetasol (Primary) ; Ulobetasol
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Valeant Pharmaceuticals International
- 25 Apr 2017 Status changed from recruiting to completed.
- 15 Aug 2016 Status changed from not yet recruiting to recruiting.
- 31 May 2016 New trial record